Search
FORT LAUDERDALE, (MARCH 7, 2024) – In joining Saul Ewing as a new partner, Zachary Kobrin brings his insight from having served as general counsel for two companies to his work as a transactional and regulatory lawyer with a focus on cannabis, antitrust and other corporate law. He works in the firm...
Please join Saul Ewing LLP and ARIAS U.S. for a half-day educational workshop and networking opportunity. For event inquiries, please contact info@arias-us.org . Panel Discussions Primer on Mass Tort Bankruptcies and Insolvencies The Current Lay of the Land, Including Scottish Re, Arrowood...
This month’s Friday Five covers cases relating to an alleged conflict of interest leading to discovery, two courts’ opposite treatments of subjective pain complaints, a decision that claims of fraud and misrepresentation were not preempted by ERISA and a court’s deference to an insurer’s...
Stephanie Denker, Partner at Saul Ewing LLP, will be speaking at a webinar entitled " Legal Update: A Discussion of Significant Insurance and Reinsurance Cases from 2022 and 2023" on February 27, 2024. The ARIAS•U.S. Law Committee will host this webinar which is focused on significant insurance and...
On February 14, 2024, the Delaware Office of Marijuana Control (OMC) released draft regulations for the state’s adult-use cannabis market. Public comment is due on or before March 29, 2024. These regulations include the rules applicable to the licensing of adult-use cannabis businesses; the...
New requirements arising from the Corporate Transparency Act of 2019 took effect on Jan 1, 2024. If your small business is formed as an entity that meets the definition of a “Reporting Company” under the Act, your organization will have to report information about their beneficial owners, i.e., the...
2023 was an active year in both the cannabis and psychedelics spaces, with significant developments across policy, research, litigation, and beyond. While states have largely led on the policy front, we expect increased federal attention in both areas this year, in addition to continuation of state...
Saul Ewing attorneys hosted a timely discussion on topics relating to Minnesota’s new adult-use cannabis law. During this one-hour program, we examined the implications of the law for all Minnesota employers, including those relating to drug testing and drug-free workplace policies. We also...
This month’s Friday Five explores decisions regarding the transfer of an ERISA action that was filed in a state where an insurer did not maintain sufficient minimum contacts, an award of attorneys’ fees, costs, and prejudgment interest, deference to an insurer’s interpretation of a plan’s provisions...
Breaking (free from) the Bank: Cannabis Litigation Finance This panel provides an overview of litigation finance, explores unique aspects of cannabis litigation that make cannabis litigation finance necessary, and provides resources for cannabis attorneys and their clients as they explore litigation...
Attorney Jonathan Havens outlines what stood out for him most after reviewing the 252-page document released by the U.S. Department of Health & Human Services.